Alveolar ridge and maxillary sinus augmentation using rhBMP-2: A systematic review

Clinical Implant Dentistry and Related Research

Volumn 17, Issue S1, 2015, Pages e192-e201

  de Freitas, Rubens Moreno ^a,d   Spin Neto, Rubens ^b   Junior, Elcio Marcantonio ^a   Pereira, Luís Antônio Violin Dias ^c   Wikesjö, Ulf Me ^d   Susin, Cristiano ^d  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Alveolar ridge augmentation; BMP; Bone morphogenetic proteins; Bone regeneration; Maxillary sinus augmentation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALVEOLAR RIDGE AUGMENTATION; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; DRUG EFFECTS; HUMAN; PROCEDURES; SINUS FLOOR AUGMENTATION;

ABSORBABLE IMPLANTS; ALVEOLAR RIDGE AUGMENTATION; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; HUMANS; OSTEOGENESIS; RECOMBINANT PROTEINS; SINUS FLOOR AUGMENTATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84885016348     PISSN: 15230899     EISSN: 17088208     Source Type: Journal    
DOI: 10.1111/cid.12156     Document Type: Article

References (42)

1. Wikesjö UME, Qahash M, Huang YH, Xiropaidis A, Polimeni G, Susin C. Bone morphogenetic proteins for periodontal and alveolar indications; biological observations - clinical implications. Orthod Craniofac Res 2009; 12:263-270.
2. Wildburger A, Payer M, Jakse N, Strunk D, Etchard-Liechtenstein N, Sauerbier S. Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone substitute - a split-mouth pilot study. Clin Oral Implants Res 2013 [Epub ahead of print].
3. Urist MR. Bone: formation by autoinduction. Science 1965; 150:893-899.
4. Wozney JM, Rosen V, Celeste AJ, etal. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242:1528-1534.
5. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992; 32:160-167.
6. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2:1-13.
7. Bessa PC, Casal M, Reis RL. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2008; 2:81-96.
8. Jung RE, Glauser R, Schärer P, Hämmerle CH, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003; 14:556-568.
9. Carter TG, Brar PS, Tolas A, Beirne OR. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans. J Oral Maxillofac Surg 2008; 66:1417-1425.
10. Herford AS, Boyne PJ. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 2008; 66:616-624.
11. Misch CM. Bone augmentation of the atrophic posterior mandible for dental implants using rhBMP-2 and titanium mesh: clinical technique and early results. Int J Periodontics Restorative Dent 2011; 31:581-589.
12. Boyne PJ, Lilly LC, Marx RE, etal. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 2005; 63:1693-1707.
13. Triplett RG, Nevins M, Marx RE, etal. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary sinus floor augmentation. J Oral Maxillofac Surg 2009; 67:1947-1960.
14. Fiorellini JP, Howell TH, Cochran D, etal. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005; 76:605-613.
15. Bianchi J, Fiorellini JP, Howell TH, etal. Measuring the efficacy of rhBMP-2 to regenerate bone: a radiographic study using a commercially available software program. Int J Periodontics Restorative Dent 2004; 24:579-587.
16. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000; 71:1241-1257.
17. Howell TH, Fiorellini J, Jones A, etal. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997; 17:124-139.
18. Boyne PJ, Marx RE, Nevins M, etal. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997; 17:11-25.
19. Kao DW, Kubota A, Nevins M, Fiorellini JP. The negative effect of combining rhBMP-2 and Bio-Oss on bone formation for maxillary sinus augmentation. Int J Periodontics Restorative Dent 2012; 32:61-67.
20. Sucato DJ, Hedequist D, Zhang H, Pierce WA, O'Brien SE, Welch RD. Recombinant human bone morphogenetic protein-2 enhances anterior spinal fusion in a thoracoscopically instrumented animal model. J Bone Joint Surg Am 2004; 86-A:752-762.
21. Faria ML, Lu Y, Heaney K, Uthamanthil RK, Muir P, Markel MD. Recombinant human bone morphogenetic protein-2 in absorbable collagen sponge enhances bone healing of tibial osteotomies in dogs. Vet Surg 2007; 36:122-131.
22. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. 2008). Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 2008; 43:931-940.
23. Stancoven BW, Lee J, Dixon DR, etal. Effect of systemic parathyroid hormone (1-34), bone morphogenetic protein-2, and demineralized bone matrix on local bone formation in the rat calvarial critical-size defect model. J Periodontal Res 2013; 48:243-251.
24. Toriumi DM, Kotler HS, Luxenberg DP, Holtrop ME, Wang EA. Mandibular reconstruction with a recombinant bone-inducing factor. Functional, histologic, and biomechanical evaluation. Arch Otolaryngol Head Neck Surg 1991; 117:1101-1112.
25. Boyne PJ. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 1996; 19:83S-92S.
26. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjö UME. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997; 8:367-374.
27. Wikesjö UME, Qahash M, Thomson RC, etal. Space-providing expanded polytetrafluoroethylene devices define alveolar augmentation at dental implants induced by recombinant human bone morphogenetic protein 2 in an absorbable collagen sponge carrier. Clin Implant Dent Relat Res 2003; 5:112-123.
28. Wikesjö UME, Qahash M, Thomson RC, etal. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 2004; 15:194-204.
29. Hanisch O, Tatakis DN, Boskovic MM, Rohrer MD, Wikesjö UME. Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2. Int J Oral Maxillofac Implants 1997; 12:604-610.
30. Hanisch O, Tatakis DN, Rohrer MD, Wöhrle PS, Wozney JM, Wikesjö UME. Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates. Int J Oral Maxillofac Implants 1997; 12:785-792.
31. Lee J, Susin C, Rodriguez NA, etal. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: relative efficacy of autogenous fresh particulate iliac bone grafts. Clin Oral Implants Res 2013; 24:497-504.
32. Jovanovic SA, Hunt DR, Bernard GW, etal. Long-term functional loading of dental implants in rhBMP-2 induced bone. A histologic study in the canine ridge augmentation model. Clin Oral Implants Res 2003; 14:793-803.
33. Wikesjö UME, Xiropaidis AV, Qahash M, etal. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs. J Clin Periodontol 2008; 35:985-991.
34. Wikesjö UME, Qahash M, Polimeni G, etal. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: histologic observations. J Clin Periodontol 2008; 35:1001-1010.
35. Keller EE, Triplett WW. Iliac bone grafting: review of 160 consecutive cases. J Oral Maxillofac Surg 1987; 45:11-14.
36. Misch CM, Misch CE. The repair of localized severe ridge defects for implant placement using mandibular bone grafts. Implant Dent 1995; 4:261-267.
37. Touzet S, Ferri J, Wojcik T, Raoul G. Complications of calvarial bone harvesting for maxillofacial reconstructions. J Craniofac Surg 2011; 22:178-181.
38. Esposito M, Grusovin MG, Rees J, etal. Interventions for replacing missing teeth: augmentation procedures of the maxillary sinus. Cochrane Database Syst Rev 2010: CD008397.
39. ten Heggeler JM, Slot DE, van der Weijden GA. Effect of socket preservation therapies following tooth extraction in non-molar regions in humans: a systematic review. Clin Oral Implants Res 2011; 22:779-788.
40. Carragee EJ, Baker RM, Benzel EC, etal. A biologic without guidelines: the YODA project and the future of bone morphogenetic protein-2 research. Spine J 2012; 12:877-880.
41. Laine C, Guallar E, Mulrow C, etal. Closing in on the truth about recombinant human bone morphogenetic protein-2: evidence synthesis, data sharing, peer review, and reproducible research. Ann Intern Med 2013; 158:916-918.
42. Resnick D, Bozic KJ. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information? Ann Intern Med 2013; 158:912-913.